medigraphic.com
ISSN 1727-897X (Electronic)

2022, Number 4

<< Back Next >>

Medisur 2022; 20 (4)

Long-term post-COVID-19 sequelae. A review study

Rosales-Márquez C, Castillo SEF

Language: Spanish
References: 31
Page: 733-744
PDF size: 1062.15 Kb.


ABSTRACT

At present, investigations are more frequent in which it is reported that survivors of the SARS-CoV-2 infection do not regain their state of health prior to the viral process. The study collected information about the various sequelae recorded in original research indexed in databases such as Scielo, Scopus, and Pubmed, 11 articles were found from patients who had COVID-19, who participated in various studies in the post-acute stage of the acute disease process. the disease, some of them were even evaluated after 6 months of having started the symptoms, however, they continued presenting symptoms after the remission of the disease. In other articles, patients were evaluated by imaging tests such as computed axial tomography and cardiac magnetic resonance imaging. The results indicated sequelae in the respiratory system such as dyspnea, fatigue, lesions compatible with pulmonary fibrosis; while, in the cardiovascular system, sequelae such as tachycardia, palpitations, arterial hypertension, myocarditis and pericardial effusion were reported. Likewise, sequelae such as headache, ageusia, anosmia, insomnia, amnesia and concentration deficit were evidenced in the nervous system; In the musculoskeletal system, arthralgia, myalgia, difficulty moving, and, finally, in mental health, the conditions recorded were anxiety, post-traumatic stress disorder, depression, apathy, dysphoria, and feelings of inferiority.


REFERENCES

  1. Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA[Internet]. 2020 [citado 4/06/2021];324(8):[aprox. 11 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32648899/1.

  2. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health[Internet]. 2020[citado 11/06/2021];13(5):[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32340833/2.

  3. Iser B, Sliva I, Raymundo VT, Poleto M, Schuelter F, Bobinski F. Suspected COVID-19 case definition: a narrative review of the most frequent signs and symptoms among confirmed cases. Epidemiol Serv Saude[Internet]. 2020[citado 07/06/2021];29(3):[aprox. 10 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32609142/3.

  4. Lake M. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond)[Internet]. 2020[citado 16/06/ 2021];20(2): [aprox. 3 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32139372/4.

  5. Mayoral V, Pérez C, Pérez J, Canós A. Sociedad Española del Dolor (SED). Recomendaciones asistenciales para unidades de dolor ante la normalización progresiva de la actividad durante la pandemia por COVID-19. Rev Soc Esp Dolor[Internet]. 2020[citado 20/06/2021];27(3):[aprox. 23 p.]. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-804620200003000085.

  6. Vellas C, Delobel P, De Souto P, Izopet, J. COVID-19, Virology and geroscience: A perspective. J Nutr Health Aging[Internet]. 2020[cited 10/06/2021];24(7):[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32744561/6.

  7. Sanders J, Monogue M, Jodlowski T, Cutrell J. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA[Internet]. 2020[citado 12/06/2021];323(18):[aprox. 12 p]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32282022/7.

  8. Bourgonje A, Abdulle A, Timens W, Hillebrands J, Navis G, Gordijn S, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol[Internet]. 2020[citado 14/06/ 2021]; 251(3):[aprox. 20 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32418199/8.

  9. Esposito S, Noviello S, Pagliano P. Update on treatment of COVID-19: ongoing studies between promising and disappointing results. Infez Med[Internet]. 2020[citado 10/06/ 2021];28(2):[aprox. 13 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32335561/9.

  10. Guillermo Esposito C, Casais P, Cesarman G, Andrade-Orsi F, Martínez R, De Campos J, et al. Guía de profilaxis y tratamiento antitrombótico para pacientes con COVID-Consenso del Grupo Cooperativo Latinoamericano en Hemostasia y Trombosis (CLAHT). Arch Cardiol Mex. 2021;91(Supl2):47-54.

  11. Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A systematic review of imaging findings in 919 Patients. AJR Am J Roentgenol[Internet]. 2020[citado 10/06/2021];215(1):[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32174129/11.

  12. D'Andréa J, Brech G, Quintana M, de Seixas A, Castilho A. Impacts of covid-19 on the immune, neuromuscular, and musculoskeletal systems and rehabilitation. Rev Bras Med Esporte[Internet]. 2020[citado 15/06/2021];26(4):[aprox. 3 p.]. Disponible en: https://www.scielo.br/j/rbme/a/BFf6PYVqkSc3cbNvXg9cG4j/?lang=en12.

  13. Klok F, Boon G, Barco S, Endres M, Geelhoed J, Knauss S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J[Internet]. 2020[citado 15/06/ 2021];56(1):[aprox. 13 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236834/ 13.

  14. Towsend L, Dyer S, Jones K, Dunne J, Mooney F, O'Connor L, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One[Internet]. 2020[citado 16/06/ 2021];15(11):[aprox. 8 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33166287/14.

  15. Torres R, Solis L, Sitjà M, Vilaró J. Functional limitations post-COVID-19: a comprehensive assessment strategy. Arch Bronconeumol[Internet]. 2020[citado 19/06/ 2021];57(1):[aprox. 2 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455248/15.

  16. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet[Internet]. 2021[citado 19/06/2021];397(10270):[aprox. 12 p.]. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32656-8/fulltext16.

  17. Moreno O, Merino E, León J, Andrés M, Ramos J, Arenas J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect[Internet]. 2021[citado 19/06/2021];82(3):[aprox. 5 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33450302/17.

  18. Cimas J. Seguimiento de los pacientes con secuelas no respiratorias de la COVID-19. FMC[Internet]. 2021[citado 17/06/2021];28(2):[aprox. 8 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909903/18.

  19. Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol[Internet]. 2020[citado 17/06/2021];93(2):[aprox. 9 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32729939/19.

  20. Fang Y, Zhou J, Ding, X, Ling G, Yu S. Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience. Am J Emerg Med [Internet]. 2020[citado 17/06/2021];38(10):[aprox. 4 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368908/20.

  21. Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging[Internet]. 2020[citado 10/06/ 2021];13(11):[aprox. 9 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214335/21.

  22. Cué M, Díaz G, Díaz A, Valdés M. El artículo de revisión. Rev Cubana de Salud Pública[Internet]. 2008[citado 19/06/ 2021];34(4):[aprox. 10 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-3466200800040001122.

  23. Vera O. Como escribir artículos de revision. Rev Med La Paz[Internet]. 2009[citado 14/06/2021];15(1):[aprox. 6 p.]. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-8958200900010001023.

  24. Goërtz Y, Van M, Delbressine J, Vaes A, Meys R, Machado F, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?. ERJ Open Res[Internet]. 2020[citado 22/06/ 2021];6(4):[aprox. 20 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491255/24.

  25. Shoucri S, Purpura L, De Laurentis C, Adan M, Theodore D, Irace A, et al. Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series. BMJ Open[Internet]. 2021[citado 24/06/2021];11(6):[aprox. 8 p.]. Disponible en: https://europepmc.org/article/PMC/818275025.

  26. Carfi A, Bernabei R, landi F. Persistent symptoms in patients after acute COVID-19. JAMA[Internet]. 2020[citado 23/06/2021];324(6):[aprox. 3 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32644129/26.

  27. Garrigues E, Janvier P, Kherabi Y, Le A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect[Internet]. 2020[citado 25/06/2021];81(6):[aprox. 3 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445491/27.

  28. Carvalho C, Laurent E, Lemaignen A, Beaufils E, Bourbao C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect[Internet]. 2021[citado 25/06/2021];27(2):[aprox. 5 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33031948/28.

  29. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect [Internet]. 2021[citado 25/06/2021];27(1):[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32979574/29.

  30. Puntmann V, Ludovica M, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol[Internet]. 2020[citado 25/06/2021];27(2):[aprox. 8 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32730619/30.

  31. Rajpal S, Tong M, Borchers J, Zareba K, Obarski T, Simonetti O, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol[Internet]. 2021[citado 25/06/ 2021];6(1):[aprox. 3 p.]. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32915194/ 31.




2020     |     www.medigraphic.com